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Gender Differences in Bile Acids 
and Microbiota in Relationship 
with Gender Dissimilarity in 
Steatosis Induced by Diet and FXR 
Inactivation
Lili Sheng1, Prasant Kumar Jena1, Hui-Xin Liu1, Karen M. Kalanetra2, Frank J. Gonzalez  3, 
Samuel W. French4, Viswanathan V. Krishnan1,5, David A. Mills2 & Yu-Jui Yvonne Wan1
This study aims to uncover how specific bacteria and bile acids (BAs) contribute to steatosis induced 
by diet and farnesoid X receptor (FXR) deficiency in both genders. A control diet (CD) and Western diet 
(WD), which contains high fat and carbohydrate, were used to feed wild type (WT) and FXR knockout 
(KO) mice followed by phenotyping characterization as well as BA and microbiota profiling. Our data 
revealed that male WD-fed FXR KO mice had the most severe steatosis and highest hepatic and 
serum lipids as well as insulin resistance among the eight studied groups. Gender differences in WD-
induced steatosis, insulin sensitivity, and predicted microbiota functions were all FXR-dependent. 
FXR deficiency enriched Desulfovibrionaceae, Deferribacteraceae, and Helicobacteraceae, which 
were accompanied by increased hepatic taurine-conjugated cholic acid and β-muricholic acid as well 
as hepatic and serum lipids. Additionally, distinct microbiota profiles were found in WD-fed WT mice 
harboring simple steatosis and CD-fed FXR KO mice, in which the steatosis had a potential to develop 
into liver cancer. Together, the presented data revealed FXR-dependent concomitant relationships 
between gut microbiota, BAs, and metabolic diseases in both genders. Gender differences in BAs and 
microbiota may account for gender dissimilarity in metabolism and metabolic diseases.
Women and men differ substantially regarding the degree of insulin sensitivity, body composition, energy bal-
ance, and the incidence of metabolic diseases1, 2. The mechanisms accounting for gender difference in metabolism 
and metabolic disease remain to be established. The liver receives 70% of its blood from the intestine and is con-
stantly exposed to intestinal-derived metabolites. Therefore, gut dysbiosis plays a crucial role in the development 
of metabolic diseases3. Whether gut-derived signaling explains the gender difference in metabolism as well as 
metabolic diseases remains to be explored. In addition, the pathways linking microbiota and metabolism remain 
to be fully established. Bile acids (BAs), which are jointly generated by hepatic and bacterial enzymes, play a 
crucial role in regulating metabolism as well as immune response4–19. Thus, microbiota can modulate host metab-
olism through modification of BAs as well as farnesoid X receptor (FXR) signaling20–23. The current study exam-
ined the relationship between microbiota and BAs in the development of metabolic syndrome in both genders. 
We hypothesize that gender differences in metabolic disease are in part due to gender disparity in microbiota and 
their associated BAs.
About 20–30% of patients who have steatosis develop steatohepatitis, of which only 15–25% progress to fibro-
sis and cirrhosis24, 25. In addition, 80% of obese patients have non-alcoholic fatty liver disease (NAFLD), but up 
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to 16% of lean people also have NAFLD26. We question whether all steatosis is identical. In rodents, high-fat 
diet (HFD) alone induces obesity and steatosis, but not liver cancer. HFD also causes dysregulated BA synthe-
sis. However, FXR knockout (KO) mice, which also have dysregulated BA synthesis, are leaner than wild type 
(WT) mice, and spontaneously develop steatosis that progresses to steatohepatitis and tumorigenesis when they 
are about 14 months old11, 27–30. In contrast to the whole body FXR KO, liver cancer formation is not noted in 
organ-specific FXR KO mice31. The clinical relevance of FXR KO mice has been revealed based on reduced FXR 
being found in patients who have liver cirrhosis and cancer32, 33. Thus, the current study examined the signaling 
that may account for progression of metabolic diseases using the whole body FXR KO mouse model.
HFD (36% fat and 14% sugar) is frequently used to study steatosis. Because of the significant role of FXR 
and BAs in regulating carbohydrate metabolism, it is important to examine the impact of sugar overload in FXR 
KO mice. In addition, ketogenic HFD actually reduces body weight, which may not be relevant to obesity34. 
Moreover, methionine and choline deficient diet-induced steatosis can lead to liver cancer in rodents, but such 
diet improves insulin sensitivity35. The Western dietary pattern is a meat-sweet diet, which is fat and sugar over-
loaded. Therefore, for the first time, the design for current study is to allow WT and FXR KO mice of both genders 
to have a free access to a Western diet (WD, 21% fat and 34% sucrose) that contains more table sugar but less fat 
compared with HFD to uncover the microbiota and BAs associated with fat as well as sugar overload.
Our results revealed that mice harboring steatosis induced by Western diet intake or FXR deficiency had a 
distinct gut microbiota profile. WD feeding of FXR KO mice further increased the severity of steatosis, which was 
worse in male than female mice. Specific BAs and microbiota associated with differential susceptibility to insulin 
resistance and steatosis were uncovered. In addition, gender differences in insulin sensitivity, WD-induced steato-
sis, and predicted microbiota functions were FXR-dependent. This study provides novel insights into the preven-
tion and treatment of metabolic diseases by targeting specific microbiota based on gender and disease etiology.
Results
FXR deficiency leads to gender difference in WD-induced steatosis. WD induced body weight 
gain (Fig. 1A), but FXR KO mice were leaner than their WT counterparts regardless of gender or diet con-
sumed (Fig. 1A). However, FXR deficiency did not affect food intake (Kcal/g body weight/day) (data not shown). 
Although females were leaner than males, their food intake was about 30% more than the males (data not shown). 
WD-fed FXR KO mice had elevated liver-to-body weight ratios (hepatomegaly), ALT (alanine aminotransferase), 
and serum LPS (lipopolysaccharide) (Fig. 1B–D), indicating WD as well as FXR inactivation increased liver 
injury and inflammatory signaling, which might compromise lipid metabolism.
Both WD and FXR deficiency induced steatosis (Fig. 1E, Supplementary Fig. S1A). Though the degree of ste-
atosis was similar in WD-fed WT mice of both genders, it became more serious in WD-fed FXR KO male mice 
than the female counterparts indicating gender difference in WD-induced steatosis was FXR-dependent (Fig. 1E, 
Supplementary Fig. S1A). WD intake and lack of FXR increased hepatic triglyceride levels and male WD-fed 
FXR KO mice had highest hepatic triglyceride level (Fig. 1F). However, hepatic cholesterol levels were increased 
by WD intake in WT mice, but not by FXR deficiency (Fig. 1G). Because FXR KO mice had elevated BAs (shown 
below), it might imply that hepatic cholesterol was quickly converted into BAs. Moreover, WD-fed FXR KO male 
mice also had the highest serum triglyceride and cholesterol levels (Fig. 1H,I). Ileal histology was not distinctly 
changed among eight studied groups (Supplementary Fig. S1B). However, the expression levels of ileal genes 
changed significantly as shown below.
Gender difference in insulin sensitivity is FXR-dependent. Although FXR KO mice were much leaner 
than WT mice, the fasting blood glucose levels were higher in control diet (CD)-FXR KO than WT mice, but they 
became similar when mice consumed WD (Fig. 2A). Insulin tolerance test (ITT) revealed gender difference in 
insulin sensitivity was apparent in CD-fed WT mice, but abolished due to FXR deficiency under the same diet 
(Fig. 2B). However, gender difference in ITT remained in WD-fed FXR KO mice. In addition, WD intake and 
lack of FXR were equally effective in inducing insulin resistance in females (Fig. 2B). In contrast, among males, 
increased insulin resistance was only noted when FXR KO mice consumed WD (Fig. 2B). Among eight groups, 
male WD-fed FXR KO mice were the most insulin resistant. Glucose tolerance test (GTT) results were similar to 
fasting glucose data (Fig. 2C).
Differential BA dysregulations induced by diet and FXR deficiency in both genders. WD intake 
shifted hepatic BA profiles, but not total hepatic BA concentration (Fig. 3, Supplementary Table S1). Notably, WD 
increased the concentration of taurine-conjugated α,β-MCA (T-α,β-MCA) in male mice of both genotypes. The 
level of α-muricholic acid (α-MCA) and β-MCA was significantly higher in WD than CD-fed FXR KO mice of 
both genders. In addition, WD-fed FXR KO mice had elevated UDCA (ursodeoxycholic acid), HDCA (hyodeox-
ycholic acid), and TLCA (taurolithocholic acid) than CD-fed counterparts in male mice.
FXR deficiency significantly increased total hepatic BAs and altered BA profiles (Fig. 3A,B). Moreover, 
WD-fed FXR KO male mice had the highest concentrations of most BAs, and such changes were accompanied by 
increased hepatic and serum lipids levels shown in Fig. 1. Hepatic T-α,β-MCA and taurine-conjugated cholic acid 
(TCA) were consistently elevated due to lack of FXR in both genders (Fig. 3, Supplementary Table S1). Moreover, 
the concentration of β-MCA and DCA (deoxycholic acid) was increased in male FXR KO in comparison with 
their WT counterparts. BA profile, but not total hepatic BA, was different between the genders. Hepatic UDCA 
and HDCA were consistently higher in males than females.
Gender differences in the expression of lipid and BA homeostasis genes. Gender difference in 
expression of lipid related genes was FXR-dependent (Fig. 4A). WD-induced fatty acid synthase (Fas) mRNA was 
not found in female FXR KO mice and gender difference in Fas level was apparent in FXR KO mice. Similarly, 
www.nature.com/scientificreports/
3Scientific RepoRts | 7: 1748  | DOI:10.1038/s41598-017-01576-9
gender differences in Col1a1 (collagen type I alpha 1) and Timp1 (tissue inhibitor of metalloproteinases 1) mRNA 
levels were apparent in WD-fed FXR KO mice. Ceramides are implicated in the development of steatosis21. 
WD-induced Smpd3 (sphingomyelin phosphodiesterase 3) expression was also much greater in male than female 
mice. These findings may explain in part the gender-difference in steatosis found in WD-fed FXR KO mice. In 
contrast, all 4 groups of female mice had higher fatty acid translocase Cd36 and fatty acid omega-hydroxylase 
Cyp4a14 mRNA levels suggesting rapid lipid uptake as well as oxidation in female mice (Fig. 4A). The expression 
level of gluconeogenic genes Pepck (phosphoenolpyruvate carboxykinase) and G6Pase (glucose-6-phosphatase) 
was also gender different in most cases, but gender disparity was lacking in WD-fed FXR KO mice.
Gender differences in expression of BA homeostasis genes were also noted (Fig. 4B). For example, the level of 
Cyp7a1 (cholesterol 7 alpha-hydroxylase) mRNA, which was similar in WT mice of both genders, was increased 
due to FXR deficiency and was higher in FXR KO females than males. In addition, the expression levels of Bsep 
(bile salt export pump) and Ostβ (organic solute transporter β) were higher in female WT mice and reduced in 
FXR KO mice. The levels of Cyp7b1 (oxysterol 7α-hydroxylase) and Cyp27a1 (sterol 27-hydroxylase), which 
generate CDCA (chenodeoxycholic acid) leading to the production of α- and β-MCA, were higher in males 
than females. These findings may in part explain elevated concentrations of those free BAs found in males shown 
in Fig. 3B. In addition, such gender gaps were narrowed due to FXR inactivation. Moreover, Sult2a1 (bile salt 
Figure 1. Histological and phenotypic changes in control diet and Western diet-fed wild type and FXR KO 
mice of both genders. (A) Body weight gain. (B) Percentage of liver to body weight ratio. (C) Serum alanine 
aminotransferase (ALT). (D) Serum endotoxin level. (E) Representative liver morphology and H&E-stained 
liver sections. Scale bars, 100 µm. Hepatic triglycerides (F) and cholesterol (G) level. Serum triglycerides (H) 
and cholesterol (I) level. n = 6 per group. Data are expressed as mean ± SD. One-way ANOVA with Tukey’s 
correction. *p < 0.05, **p < 0.01, ***p < 0.001 for diet comparison; #p < 0.05, ##p < 0.01, ###p < 0.001 for 
genotype comparison; &p < 0.05, &&p < 0.01, &&&p < 0.001 for gender comparison.
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sulfotransferase) level was much higher in females than males suggesting better sulfation-mediated detoxifi-
cation in females (Fig. 4B). The highly elevated TCA and T-α,β-MCA in FXR KO mice were correlated with 
increased Cyp7a1. In addition, hepatic BA conjugation gene Baat (bile acid-CoA:amino acid N-acyltransferase) 
was reduced by both WD intake and FXR inactivation. Moreover, in the ileum, the expression level of tight junc-
tion genes was reduced by WD and FXR deficiency (Supplementary Fig. S2), suggesting the increased intestinal 
permeability in these mice.
Divergent gut dysbiosis induced by diet and FXR-deficiency in both genders. WD shifted the gut 
microbiota in a FXR-dependent manner. The most significant changes caused by FXR deficiency were Firmicutes 
reduction and Proteobacteria increase (Fig. 5A, Supplementary Table S2). The WD-increased Firmicutes to 
Bacteroidetes ratio in obese WT mice was not found in leaner FXR KO mice showing FXR dependency (Fig. 5B). 
Additionally, Firmicutes/Bacteroidetes was reduced due to FXR deficiency. Furthermore, it is apparent that 
WD-fed WT and CD-fed FXR KO mice acquired distinctive patterns of dysbiosis despite both models generating 
similar severity of steatosis (Fig. 5A). The shifted microbiota at the family level, which was based on diet, pheno-
type, and gender, was revealed by principal component analysis (PCA). Examples are shown in Fig. 5C–E and 
FXR deficiency had the greatest impact. Other comparisons showed similar patterns (data not shown).
Heatmap (Supplementary Fig. S3) and box plots (Fig. 5F,G) revealed that WD altered microbiota at the fam-
ily level in a gender and FXR-dependent manner. WD-reduced Erysipelotrichaceae and Lachnospiraceae in WT 
Figure 2. Insulin and glucose tolerance tests in control diet and Western diet -fed wild type and FXR KO mice 
of both genders. (A) Blood glucose level after 6 h fasting. (B) Insulin tolerance test (ITT). (C) Glucose tolerance 
test (GTT). The area under curve (AUC) is showed. n = 6 per group. Data are expressed as mean ± SD. One-way 
ANOVA with Tukey’s correction. *p < 0.05, **p < 0.01, ***p < 0.001 for diet comparison; #p < 0.05, ##p < 0.01, 
###p < 0.001 for genotype comparison; &p < 0.05, &&p < 0.01, &&&p < 0.001 for gender comparison.
Figure 3. Hepatic bile acid profile in control diet and Western diet-fed wild type and FXR KO mice of both 
genders. (A) Total hepatic bile acids. Data are expressed as mean ± SD. One-way ANOVA with Tukey’s 
correction, ###p < 0.001 for genotype comparison. (B) Hepatic bile acid profile. n = 16 in male groups, n = 6 in 
female groups.
www.nature.com/scientificreports/
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mice were male and female specific, respectively (Fig. 5F). WD-enriched Clostridiales_f and Clostridiaceae in 
WT mice were also male and female specific, respectively (Supplementary Fig. S3B). In addition, such changes 
were not noted in FXR KO mice. FXR deficiency reduced the abundance of Erysipelotrichaceae, Lachnospiraceae, 
S24-7 (Fig. 5F), and increased the abundance of Desulfovibrionaceae, Deferribacteraceae, and Helicobacteraceae 
(Fig. 5G). The enriched Deferribacteraceae in FXR KO mice was further increased by WD intake in both genders. 
The increase of Helicobacteraceae was particularly impressive from 1% in WT mice up to 40% in FXR KO mice 
(Fig. 5G). Moreover, gender difference was also observed. WT female mice had lower abundance of S24-7 and 
higher abundance of Bacteroidaceae, Rikenellaceae, Lactobacillaceae, and Verrucomicrobiaceae than male counter-
parts, but these gender differences were abolished due to FXR deficiency (Supplementary Fig. S3B).
The abundance of cecal bacterial genes was quantified to understand the global microbiota function. 
FXR inactivation increased the abundance of secondary BA-generating baiJ and WD further enhanced it in 
a male predominant manner (Fig. 5H). Additionally, FXR deficiency also increased the abundance of hydro-
gen sulfide-producing dsrA while substantially reducing butyrate-producing bcoA. The abundance of BA 
de-conjugation gene bsh was reduced by both WD and FXR deficiency, which was consistent with increased 
conjugated BAs in vivo (Fig. 5H).
To study the potential function of gut microbiota, PICRUSt (Phylogenetic Investigation of Communities by 
Reconstruction of Unobserved States) and LEfSe analysis (Linear discriminant analysis Effect Size) were per-
formed to predicate and identify differentially enriched pathways. The predicted microbiota functions shifted 
based on 3 variables as summarized in Table 1. According to the number of pathways differentially enriched 
Figure 4. Hepatic gene expression in control diet and Western diet -fed wild type and FXR KO mice of both 
genders. (A) Lipid and glucose related genes. (B) Bile acid related genes. n = 6 per group. Data are expressed as 
mean ± SD. One-way ANOVA with Tukey’s correction. *p < 0.05, **p < 0.01, ***p < 0.001 for diet comparison; 
#p < 0.05, ##p < 0.01, ###p < 0.001 for genotype comparison; &p < 0.05, &&p < 0.01, &&&p < 0.001 for gender 
comparison.
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between groups (LDA score >2, p < 0.05), FXR KO had the greatest impact, consistent with the PCA find-
ing shown in Fig. 5D. There were 93–161 pathways differentially enriched between WT and FXR KO groups. 
Regarding diet, there were 19 pathways differentially enriched between CD and WD-fed male WT mice, but only 
4 in FXR KO mice. In addition, diet had zero impact on changing the function of microbiota in female WT, but 
the effect was substantially increased in female KO mice (0 vs. 45 pathways) indicating FXR-dependency in reg-
ulating gut microbiota function in response to dietary challenge. Furthermore, WD enriched neurodegenerative 
disease pathways in female FXR KO mice indicating gender difference in the gut-brain axis affected by dysreg-
ulated BAs and dysbiosis. It is important to note that gender difference in microbiota function was abolished 
by FXR deficiency, and there was no differentially enriched pathway between male and female FXR KO mice 
(Table 1). Gender differences became very apparent when both genotypes of mice consumed WD consistent with 
the gender difference in steatosis.
Integrated relationships. The relationships between gut microbiota, hepatic BAs, mouse phenotypes, 
and gene expression were established. Spearman’s correlations revealed that 20 out of 34 identified bacterial 
families had strong correlations with certain mouse phenotypes (Supplementary Fig. S4). ALT, hepatic triglyc-
eride and serum cholesterol were negatively correlated with Lachnospiraceae and positively correlated with 
Deferribacteraceae (Fig. 6A). Moreover, Helicobacteraceae were positively correlated with serum triglyceride, 
cholesterol, and LPS (Fig. 6A).
In addition, 25 out of 34 identified bacterial families had strong correlations with certain BAs (Supplementary 
Fig. S5). The concentrations of T-α,β-MCA and TCA were negatively correlated with the abundance of S24-7, 
Figure 5. Diet and FXR deficiency changed gut microbiota composition in both genders. (A) Cecal microbiota 
at phylum level. (B) Firmicutes to Bacteroidetes ratio. Principal component analysis plots of cecal microbiota 
at family level based on diet (C), phenotype (D), and gender difference (E). (F) and (G), relative abundance of 
cecal microbiota at family level (Kruskal-Wallis test). Box plots display the median, 25th percentile, and 75th 
percentile; whiskers display minimum and maximum values. (H) Targeted functional quantitative PCR analysis 
of microbial genes. (B,H), data are expressed as mean ± SD. One-way ANOVA with Tukey’s correction. n = 16 
in male groups, n = 6 in female groups. *p < 0.05, **p < 0.01, ***p < 0.001 for diet comparison; #p < 0.05, 
##p < 0.01, ###p < 0.001 for genotype comparison; &p < 0.05, &&p < 0.01, &&&p < 0.001 for gender comparison.
www.nature.com/scientificreports/
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Erysipelotrichaceae, and Lachnospiraceae. T-α,β-MCA, TCA, β-MCA, and DCA were positively associated with 
the abundance of Deferribacteraceae, Helicobacteraceae, and Desulfovibrionaceae in most cases (Fig. 6A).
Between BAs and phenotypes (Supplementary Fig. S6), the male predominant UDCA and HDCA were pos-
itively associated with blood glucose levels based on GTT and ITT (Fig. 6B). In addition, UDCA, β-MCA, and 
HDCA, of which were elevated in males and/or FXR KO, were positively correlated with LPS. Most of those BAs 
showed positive correlation with ITT (Fig. 6B).
Spearman’s correlations also revealed relationships between microbiota abundance and 163 studied host genes 
(Supplementary Fig. S7). Those genes have known roles in regulating BA homeostasis, metabolism, inflamma-
tory process, cell cycle progression, etc. in the liver, ileum, spleen, and adipose tissue. There were two distinct 
clusters of clearly associated specific bacterial families (Fig. 6C, Supplementary Fig. S7). In cluster 1, major-
ity were hepatic genes implicated in inflammation or fibrosis (α-Sma, Col1a1, Cd14, Timp1, Ccl3, Ccl17, Mcp1, 
Cxcl12, Inos, Il17a, Il22, Icam1, Tgfβ, and Cxcl10), BA homeostasis (Cyp7a1 and Sult2a1), and energy and fat 
homeostasis (Fgfr1 and Cd36). Cluster 2 are genes in regulating BA homeostasis (hepatic Cyp27a1, Bsep, Shp, 
Ostβ, and ileal Ostα, Ostβ, Ibabp, Fgf15), energy homeostasis (hepatic Srebp2, ileal Pyy and Nur77), and inflam-
mation (ileal Tnfα, Tirap, Traf6, Il1β, spleen Il10, Il1β, and hepatic Il1β) (Fig. 6C). Three main bacterial phyla, 
Bacteroidetes, Firmicutes, and Proteobacteria, were clustered separately. Six families under Bacteroidetes and 
four families under Proteobacteria including Desulfovibrionaceae and Helicobacteraceae showed a positive and 
Group Number of pathway, examples of differentially enriched pathways in each group
Total 
number
Diet Control diet Western diet
Male WT 15
• Amino sugar and nucleotide sugar 
metabolism
4
• C5-Branched dibasic acid metabolism
19• Photosynthesis • Naphthalene and ethylbenzene degradation
• Alanine-Aspartate and glutamate 
metabolism • Cyanoamino acid metabolism
Male FXR KO 2
• Methane metabolism
2
• Photosynthesis
4
• Lipoic acid metabolism • Vibriocholerae pathogenic cycle
Female WT 0 0 0
Female FXR KO 20
• Starch and sucrose metabolism
25
• Bacterial motility and flagellar assembly
45
• Galactose metabolism • Fatty acid biosynthesis
• Glycolysis and gluconeogenesis
• Neurodegenerative Diseases 
(Parkinson’s, Huntington’s, Alzheimer’s 
disease)
Genotype Wild type FXR KO
CD-fed Male 29
• Transporter
64
• Lipopolysaccharide biosynthesis
93• Fructose and mannose metabolism • Fatty acid biosynthesis
• Fatty acid metabolism • Neurodegenerative Diseases
WD-fed Male 37
• Transporter
74
• Lipopolysaccharide biosynthesis
111• Transcription factors • Carbon fixation pathway in Prokaryotes
• Fructose and mannose metabolism • Bacterial secretion system
CD-fed Female 53
• Phosphotransferase system
48
• Bacterial motility proteins
101• Amino sugar and nucleotide sugar metabolism • Flagellar assembly
• Starch and sucrose metabolism • Secretion system
WD-fed Female 85
• Transporter
76
• Lipopolysaccharide biosynthesis
161• Transcription factors • Bacterial motility proteins
• Fructose and mannose metabolism • Carbon fixation pathway in Prokaryotes
Gender Male Female
CD-fed WT 4
• Bacterial motility and flagellar assembly
7
• G-protein coupled receptors
11• Bacterial chemotaxis • Glycerophospholipid metabolism
• Plant pathogen interaction • Nucleotide excision repair
WD-fed WT 8
• Methane metabolism
33
• Replication recombination and repair
41• Starch and sucrose metabolism • DNA repair and recombination
• Cyanoamino acid metabolism • Fatty acid metabolism
CD-fed FXR KO 0 0 0
WD-fed FXR KO 23
• Starch and sucrose metabolism
34
• Retinoic acid-inducible gene like 
receptor signaling pathway
57• Methane metabolism • Bacterial secretion system
• Glycolysis and gluconeogenesis • Metabolism of cofactors and vitamins
Table 1. Differentially enriched microbial pathways in each group.
www.nature.com/scientificreports/
8Scientific RepoRts | 7: 1748  | DOI:10.1038/s41598-017-01576-9
negative relationship with Cluster 1 and 2, respectively. By contrast, many families within Firmicutes, including 
FXR KO-reduced Lachnospiraceae and Erysipelotrichaceae, were positively correlated with the expression levels 
of Cluster 2 genes, but negatively associated with Cluster 1 genes.
Divergent BA profile and gut dysbiosis in Western diet and FXR deficiency-induced steato-
sis. Histologically, the steatosis induced by WD and FXR deficiency was similar (Fig. 1E, Supplementary 
Fig. S1). However, aged FXR KO mice spontaneously develop liver tumors11, 27–30. To define the difference, 
comparisons were done between WD-fed WT and CD-fed FXR KO mice of both genders. Despite having 
higher hepatic cholesterol as well as more body weight gain, WD-fed WT mice had lower hepatic TCA, DCA, 
and β-MCA, in both genders showing inferior effects of lacking FXR (Fig. 7A, Supplementary Table S3). Gut 
microbiota was also strikingly different between the two models. The PCA plots showed distinct clustering of 
WD-fed WT and CD-fed FXR KO at the bacterial family level in both genders (Fig. 7B). The abundances of 
Verrucomicrobiaceae, S24-7, Clostridiaceae, Clostridiales_f, and Erysipelotrichaceae were much higher in WD-fed 
WT mice, while Bacteroidaceae, Desulfovibrionaceae, and Helicobacteraceae were markedly higher in CD-fed FXR 
KO mice of both genders (Fig. 7C).
Discussion
Gender disparity in metabolism and metabolic disease has been long thought to be regulated intrinsically by the 
host. Our study revealed BAs and FXR as well as associated gut microbiota are implicated in the gender difference 
in metabolic diseases. By comparing WD and FXR KO-induced steatosis, our data revealed specific microbiota 
families and BAs were differentially responsible for obesity versus metabolic dysregulation-associated steatosis 
that has the potential for tumorigenesis. The data presented suggest the use of probiotics or other means in the 
prevention and treatment of metabolic disease should be tailored based on gender and other phenotypes such as 
microbiota and BA profiles.
The detrimental effects of BAs over a lifetime of exposure vary depending on their solubility, conjugation 
status, and bioactivity to their receptors. Without self-regulatory mechanisms controlled by FXR, exposure to 
high concentration of BAs may cause cholestasis, inflammation, and tumorigenesis6–8. Among the identified BAs, 
hepatic free β-MCA concentration was extremely low in CD-fed WT mice, but showed the most substantial fold 
increase as a result of WD intake, FXR deficiency, or being male (up to 15 folds). The extent of induction was pos-
itively associated with detrimental outcomes including LPS, glucose intolerance as well as serum lipids. WD-fed 
FXR KO male mice, which exhibited the worst pathological phenotype, had the highest hepatic β-MCA level. It 
is important to note that β-MCA is also detectable in humans36. Hepatic TCA concentration was increased due 
Figure 6. Spearman’s correlation analysis. Heatmaps of Spearman’s correlation analysis between abundance of 
bacterial families and phenotypes, bacterial families and hepatic bile acids (A), between mouse phenotypes and 
hepatic bile acids (B), and between abundance of bacterial families and genes (C) *p < 0.05.
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to FXR deficiency, but not WD intake. This finding was consistent with the finding that TCA concentration is 
reduced by FXR agonist (obeticholic acid) treatment4. In addition, TCA is elevated in nonalcoholic steatohep-
atitis (NASH) patients37, 38. Due to the affinity of TCA to FXR and TGR5, it is possible that the elevated TCA is 
trying to activate these receptors in order to normalize metabolism indicating a compensatory effect. Moreover, 
TCA treatment inhibited intestinal adenoma formation in mice39 and increased the circulating GLP-1, PYY, and 
insulin, thereby decreasing glucose levels in obese type 2 diabetic patients40. Consistently, our data showed that 
the elevated hepatic TCA was not significantly associated with negative outcomes including increased ALT, serum 
and hepatic triglycerides, LPS, as well as glucose level suggesting there was no negative impact for TCA induction 
in FXR KO mice (Supplementary Fig. S6). Male-predominant UDCA and HDCA were positively correlated with 
serum LPS, glucose intolerance, and insulin resistance. Elevated serum UDCA was also found in patients with 
alcoholic liver and biliary tract disease41. It would be important to further elucidate the specific effects of those 
BAs at relevant concentrations found in vivo. Taken together, FXR KO mice had obvious phenotypes on both 
genders and WD intake enhanced the gender differences.
Both WD used in the current study and HFD reduced the abundance of Bacteroidaceae and 
Erysipelotrichaceae42, 43. However, WD increased Clostridiales_f, while HFD reduced it in males42. In addition, 
HFD, but not WD, enriched the abundance of Ruminococcaceae and Rikenellaceae in males42. The WD we used 
had more carbohydrates but less fat compared with HFD. The impact of carbohydrates in metabolic disease pro-
cess remains to be delineated.
Gut microbiota is correlated with the development of obesity. However, conflicting findings persists regarding 
the relationship of obesity and the relative proportions of Firmicutes and Bacteroidetes in mice and humans stud-
ies44–47. Our data showed WD-fed obese WT mice had increased Firmicutes to Bacteroidetes ratio than CD-fed 
lean mice in both genders. In addition, obese WT mice had higher Firmicutes/Bacteroidetes than the leaner 
FXR KO mice. However, WD induced Firmicutes/Bacteroidetes was FXR dependent. Moreover, although male 
mice gained more body weight than females, the correlated ratio change was not noted. Thus, the Firmicutes/
Bacteroidetes ratio can be affected by metabolic condition and gender.
FXR has an essential role in regulating gut microbiota profile. Based on methods used, differences of micro-
biota composition in WT and FXR KO mice were reported between aerobic vs. anaerobic bacteria or based on 
selected phyla and families20, 23, 48, 49. Moreover, FXR deficiency abolished probiotic-mediated alternation of BA 
metabolism indicating the close relationship between FXR signaling pathway and gut microbiota48. The current 
study might be one of the first to compare the dietary effect in both genders based on FXR status. Our data 
showed that the abundances of Proteobacteria (from 2% to 58%) and Firmicutes (from 74% to 23%) had the 
largest changes due to FXR deficiency. Moreover, Proteobacteria was further increased by WD intake in FXR 
KO mice. Progressive increases in the abundance of Proteobacteria were also found in children who are healthy, 
obese, or have NASH50. The reduced abundance of Erysipelotrichaceae (from 37% to 0.1%) and Lachnospiraceae 
(from 10% to 6%) families can account for the substantial reduction of Firmicutes (from 74% to 23%) in FXR KO 
mice. Higher abundance of Erysipelotrichaceae was found in morbidly obese individuals44. Many Lachnospiraceae 
species generate butyrate, which regulates metabolism, immune response, and colonocyte growth51. Consistently, 
our data showed reduced abundance of butyrate-producing gene (bcoA) in the cecal content of FXR KO mice. 
Lachnospiraceae, which was reduced in colorectal cancer patients52, was negatively correlated with ALT, hepatic 
triglyceride, and serum cholesterol in current study.
Figure 7. The differences between Western diet-fed wild type mice and control diet-fed FXR KO mice of both 
genders. (A) Heatmaps of bile acid profile and mouse phenotypes. Bile acids and phenotypes were displayed with 
fold change (WD-fed WT vs. CD-fed FXR KO) ≥1.5 or ≤0.67 in at least one gender. (B) Principal component 
analysis plots of cecal microbiota at family level. (C) Bacterial families are shown (mean relative abundance 
>0.2%) with significant difference between WD-fed WT and CD-fed FXR KO mice in at least one gender.
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Desulfovibrionaceae (from 1% to 24%), Helicobacteraceae (from 1% to 33%) as well as Deferribacteraceae had 
the largest increases due to FXR deficiency. Bilophila, the major genus in the Desulfovibrionaceae family, gener-
ates hydrogen sulfide, a genotoxin and mucosal barrier-breaker. Consistently, the abundance of cecal hydrogen 
sulfide-producing gene dsrA was elevated in male FXR KO mice. Helicobacteraceae generates LPS, and its abun-
dance is correlated with hepatic DCA that has DNA damaging, pro-inflammatory, and tumor-promoting effects53. 
Helicobacteraceae family is implicated in various health issues and was positively correlated with serum triglycer-
ide and cholesterol in our study. Moreover, the expansion of Deferribacteraceae may lead to mucin deregulation, 
inflammation, and tumorigenesis in FXR KO. The correlation of ALT, hepatic triglyceride, and serum cholesterol 
with Deferribacteraceae was diametrically opposed to Lachnospiraceae, suggesting the reverse effect of these two 
families. Furthermore, the clustered Desulfovibrionaceae, Deferribacteraceae, and Helicobacteraceae were posi-
tively correlated with β-MCA, T-α,β-MCA, and TCA, which together constituted 95% of the total hepatic BA 
pool. In addition, the abundances of those three families were positively correlated with hepatic Cyp7a1 expres-
sion and negatively correlated with Shp, Bsep, and Ostβ expression, which might account for the accumulation of 
hepatic BAs in FXR KO mice.
Together, gender differences in metabolism are FXR-dependent. For examples gender difference in 
WD-induced steatosis became apparent when FXR was inactivated. However, gender differences in insulin sen-
sitivity and predicted gut microbial function were not found in FXR KO mice. Moreover, many genes regulating 
BA homeostasis or metabolism displayed a gender-dependent expression patterns, and such differences became 
either more apparent or abolished due to FXR deficiency. Furthermore, WD-induced dysbiosis as well as the 
predicted microbial functions were also gender and FXR-dependent. It is important to emphasize that FXR inac-
tivation, dysregulated BA synthesis, and dysbiosis are tightly linked. It is not possible to determine which has 
a more significant role in steatosis development. It has been shown that cholestyramine treatment reduces the 
malignant hepatic lesions in FXR KO mice indicating the significant role of BAs in liver pathology27. Additionally, 
antibiotic modification of gut microbiota prevents HFD-associated NAFLD and alters BA profiles21. Therefore, 
the presented data revealed the concomitant relationships between gut microbiota, BAs, and metabolic diseases 
in both genders in a FXR-dependent manner.
In conclusion, it is likely that gender difference in FXR signaling accounts for gender disparity in metabolism 
as well as metabolic disease process. Emerging evidence reveals the significant role of gut microbiota in contrib-
uting to gender difference in immunity54. The interactions between FXR and sex hormones warrant further inves-
tigation. It would be critically important to study gender-specific effects controlled by gut microbiota in order to 
develop tailored prevention and treatment strategy using probiotics for metabolic diseases.
Methods
Mice. C57BL/6 WT (Jackson Laboratory) and FXR KO55 mice of both genders were given a WD (21% fat, 34% 
sucrose, and 0.2% cholesterol, w/w) or CD (5% fat, 12% sucrose, and 0.01% cholesterol, w/w) from Harlan Teklad 
after weaning (3 weeks) and were euthanized at the age of 5 months. Experiments were conducted in accord-
ance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals under protocols 
approved by the Institutional Animal Care and Use Committee of the University of California, Davis.
Glucose and insulin tolerance test. After fasting 6 h, tail vein blood was used to establish fasting blood 
glucose levels. Glucose (2 g/kg body weight) and insulin (0.75 U/kg body weight, Sigma-Aldrich) were given for 
conducting glucose (GTT) and insulin (ITT) tolerance tests, respectively. Glucose levels were measured 15, 30, 
60, 90, and 120 min post treatment by the OneTouch Ultra 2 (Johnson). The area under the curve (AUC) of the 
blood glucose levels over time was calculated.
Biochemical analysis. Serum alanine aminotransferase (ALT, Pointe Scientific), lipopolysaccharide (LPS, 
Thermo Scientific), serum and hepatic triglyceride and cholesterol (BioAssay Systems) levels were quantified 
according to the manufacturer’s instructions.
Quantification of bile acids. Liver tissue (50–100 mg) was collected from fed-state mice with gallblad-
der removed following by BA extraction56. BAs were analyzed using a ProminenceTM UFLC system (Shimadzu) 
coupled to an API 4000 QTRAPTM mass spectrometer (AB Sciex) operated in the negative ionization mode. 
Chromatography was performed on a Kinetex C18 column (50 mm × 2.1 mm, 2.6 μm) maintained at 40 °C 
preceded by a high pressure column prefilter. The mobile phase consisted of methanol gradient delivered at a flow 
rate of 0.4 ml/min5.
Gene expression profiling. Tissue RNA was extracted using TRIzol Reagent (Invitrogen). cDNA was syn-
thesized using High Capacity RNA-to-cDNA Kit (Applied Biosystems). qRT-PCR was performed on an ABI 
7900HT Fast real-time PCR system using Power SYBR® Green PCR Master Mix (Applied Biosystems). Primers 
were designed using Primer3 Input Software (v0.4.0) and the sequences are available upon request. mRNA levels 
were normalized to the level of Gapdh mRNA.
Quantification of bacterial DNA and 16S rRNA gene sequencing. Cecal (0.1 gram) DNA 
was extracted using ZR Fecal DNA MiniPrep Kit (Zymo Research), quantified by NanoDrop (NanoDrop 
Technologies), and amplified using primers based on published sequences (Supplementary Table S4). A disso-
ciation step was included to analyze the melting profile of amplified products. In parallel, qPCR was done using 
ten-fold serial diluted synthetic DNA fragments of bacterial gene with known concentrations. Bacterial DNA 
concentration was calculated using standard curves of diluted synthetic DNA fragment.
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Pyrosequencing of Tagged 16S rRNA Gene Amplicons of cecal DNA was done based on published methods57. 
The V4 region of 16S rRNA gene was amplified and sequenced using Illumina MiSeq.
Bioinformatics and statistical analysis. Sequence reads were analyzed using QIIME software. 
Family-level taxa abundances were used in Statistical Analysis of Metagenomic Profiles (STAMP v.2.0) soft-
ware to generate principal component analysis (PCA) plots. Spearman’s correlations were performed with R 
Statistical Software. Functional profiles of microbial communities were predicted using PICRUSt (Phylogenetic 
Investigation of Communities by Reconstruction of Unobserved States). LEfSe analysis (Linear discriminant anal-
ysis Effect Size) was performed to identify differentially enriched pathways58. Data are expressed as mean ± SD. 
Differences between groups in microbiota family level were calculated by Kruskal-Wallis test. All other compar-
isons were calculated by two-tailed Student’s t test or one-way ANOVA followed by Tukey’s test using GraphPad 
Prism 6 software. p-values are adjusted for multiple comparison using false discovery rate. p < 0.05 was consid-
ered statistically significant.
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